Notably, IRF5 directly suppressed TGFB1—a factor promoting tissue remodeling—in adipose tissue macrophages (ATMs), highlighting its role as a checkpoint in obesity-associated inflammation [17]. Here, IRF5 is linked to obesity disorder.